Nakamura Y - Search Results

1

Effects of a modified group intervention with early-stage breast cancer patients.

Hosaka T, Sugiyama Y, Hirai K, Okuyama T, Sugawara Y, Nakamura Y. Hosaka T, et al. Among authors: nakamura y. Gen Hosp Psychiatry. 2001 May-Jun;23(3):145-51. doi: 10.1016/s0163-8343(01)00131-1. Gen Hosp Psychiatry. 2001. PMID: 11427247

2

Persistence of the benefits of a structured psychiatric intervention for breast cancer patients with lymph node metastases.

Hosaka T, Sugiyama Y, Tokuda Y, Okuyama T, Sugawara Y, Nakamura Y. Hosaka T, et al. Among authors: nakamura y. Tokai J Exp Clin Med. 2000 Jun;25(2):45-9. Tokai J Exp Clin Med. 2000. PMID: 11127506

3

Autografting with peripheral blood CD34-positive cells following high-dose chemotherapy against breast cancer.

Okumura A, Tokuda Y, Ohta M, Suzuki Y, Saito Y, Kuge S, Kubota M, Makuuchi H, Tajima T, Nakamura Y, Hotta T. Okumura A, et al. Among authors: nakamura y. Tokai J Exp Clin Med. 1999 Dec;24(4-6):141-6. Tokai J Exp Clin Med. 1999. PMID: 10819494

4

Injection of CD4(+) and CD8(+) cells with donor or host accessory cells induces acute graft-vs-host disease in human skin in immunodeficient mice.

Matsumoto M, Katoh Y, Nakamura Y, Shimakura Y, Hagihara M, Yabe H, Yabe M, Inokuchi S, Kato S, Shimamura K. Matsumoto M, et al. Among authors: nakamura y. Exp Hematol. 2001 Jun;29(6):720-7. doi: 10.1016/s0301-472x(01)00639-7. Exp Hematol. 2001. PMID: 11378267 Free article.

5

Effect of peripheral blood progenitor cell dose on hematopoietic recovery: identification of minimal progenitor cell requirements for rapid engraftment.

Miyamoto T, Shinozuka T, Maeda H, Hirasawa T, Muramatsu T, Murakami M, Makino T, Itagaki H, Nakamura Y. Miyamoto T, et al. Among authors: nakamura y. Bone Marrow Transplant. 2004 Mar;33(6):589-95. doi: 10.1038/sj.bmt.1704412. Bone Marrow Transplant. 2004. PMID: 14743198

6

Extensive generation of human cord blood CD34(+) stem cells from Lin(-)CD34(-) cells in a long-term in vitro system.

Ando K, Nakamura Y, Chargui J, Matsuzawa H, Tsuji T, Kato S, Hotta T. Ando K, et al. Among authors: nakamura y. Exp Hematol. 2000 Jun;28(6):690-9. doi: 10.1016/s0301-472x(00)00154-5. Exp Hematol. 2000. PMID: 10880755 Free article.

7

Factors that influence the eligibility of cases for inclusion in clinical trials. The Lung Cancer Chemotherapy Study Group of the Japan Clinical Oncology Group.

Kasai T, Ohe Y, Nishio K, Kunitoh H, Tamura T, Sekine I, Kubota K, Yamamoto N, Nakamura Y, Shinkai T, Kodama T, Saijo N. Kasai T, et al. Among authors: nakamura y. Jpn J Clin Oncol. 1998 Mar;28(3):214-21. doi: 10.1093/jjco/28.3.214. Jpn J Clin Oncol. 1998. PMID: 9614446

8

Optimal duration of macrolide treatment for chronic sinusitis after endoscopic sinus surgery.

Nakamura Y, Suzuki M, Yokota M, Ozaki S, Ohno N, Hamajima Y, Nakayama M, Hashiba M, Murakami S. Nakamura Y, et al. Auris Nasus Larynx. 2013 Aug;40(4):366-72. doi: 10.1016/j.anl.2012.09.009. Epub 2012 Oct 27. Auris Nasus Larynx. 2013. PMID: 23107100 Clinical Trial.

9

A new compact and cell dense continuous culture system.

Nakamura Y, Watanabe K, Noto T, Tajima T, Yamamura M. Nakamura Y, et al. J Immunol Methods. 1989 Mar 10;118(1):31-5. doi: 10.1016/0022-1759(89)90049-5. J Immunol Methods. 1989. PMID: 2926150

10

Bezafibrate increases prebeta 1-HDL at the expense of HDL2b in hypertriglyceridemia.

Miida T, Sakai K, Ozaki K, Nakamura Y, Yamaguchi T, Tsuda T, Kashiwa T, Murakami T, Inano K, Okada M. Miida T, et al. Among authors: nakamura y. Arterioscler Thromb Vasc Biol. 2000 Nov;20(11):2428-33. doi: 10.1161/01.atv.20.11.2428. Arterioscler Thromb Vasc Biol. 2000. PMID: 11073848

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,635 results

Search Page

Filters